SproutNews logo

Philadelphia Power Morcellator Lawsuit Alleges PKS PlasmaSORD Spread Uterine Cancer Cells In Patient

January 04, 2016 – – Banville Law reports on a power morcellator lawsuit which was initially filed in Philadelphia, Pennsylvania against the company that manufactures the PKS PlasmaSORD Bipolar Morcellator. The case was filed by a couple who allege that the device dangerously spread and accelerated cancer cells in the woman’s body during a gynecological surgery on uterine fibroids.

Laparoscopic power morcellation provides a minimally invasive surgery option for patients undergoing myomectomies, hysterectomies, and other gynecological surgeries involving uterine fibroids. It can be done with a power morcellator device, which is able to enter the body through just a small incision, allowing a faster, less painful recovery for the patient involved.

Once inside the abdomen, the power morcellator device works much like a drill, spinning tiny blades which are designed to shred the troublesome uterine fibroid tissue. Once the fibroid tissue is shredded into tiny pieces, it is able to be removed from the body through the incision. During this process, however, many now allege that the power morcellator device can expose and then spread cancer cells that the patients and doctors were previously unaware of, creating an advanced, high-grade cancer, and greatly impacting the patient’s life-expectancy.

This surgery is just one of many increasingly popular surgeries designed to eliminate the need for large incisions by using scopes that contain tiny parts and tiny cameras, which are able to be deployed to perform these surgical procedures through just a small incision. When used in the abdomen, this is generally termed a laparoscopy. Rather than creating a large incision across the abdomen, it allows minimally invasive surgery to take place.

Due to the cancer-spreading risks involved, certain hospitals have worked harder to develop ways to contain the shredded tissue during the morcellation procedure, but many have begun to stop using power morcellation during gynecological surgeries completely. Several recent studies show that nationally, the procedure is used less and less, following a safety warning by the U.S. Food and Drug Administration which indicated that power morcellation should not be used on uterine fibroids, due to the fact that it could spread cancerous cells.

The U.S. FDA also estimated that around 1 in every 350 women who undergo power morcellation to remove fibroids may have undetected cancer cells encapsulated within those fibroids. If exposed and spread through this process, the health and long term-survival of the patient would be greatly impaired.

This particular lawsuit alleges much the same. The suit claims that the PKS PLasmaSORD Bipolar Morcellator used during the woman’s gynecological surgery had succeeded in exposing and spreading cancer cells throughout the woman’s abdomen. The fibroids being removed, prior to surgery, were thought to be benign tumors. If cancer cells are encapsulated within a uterine fibroid, they are virtually impossible to detect before surgery.

The morcellator used during this procedure is one of many produced by various manufacturers. In this case, the manufacturer and defendant is Gyrus Acmi LP, a subdivision of Olympus Corporation. Details of the lawsuit, originally filed in the Court of Common Pleas in PA under case number 150900680, state: “The PKS PlasmaSORD Bipolar Morcellator disseminated and seeded cancer throughout plaintiff’s abdominal cavity, thereby causing and accelerating the metastases and spread of her cancer, worsening the long-term prognosis and the natural course of her cancer. The spread of the life-threatening cancer suffered by the plaintiff was a direct result of the use of the PKS PlasmaSORD Bipolar Morcellator during her 2011 surgical procedure.”

Today, as lawsuits filed against manufacturers of these devices continue to rise, the attorneys at Banville Law are working to ensure that everyone involved will have the ability to explore their legal rights. Women who have undergone laparoscopic power morcellation procedures and who were subsequently diagnosed with cancer may be entitled to significant compensation. Banville Law is currently offering free power morcellator consultations for those affected.

To ask questions or request additional information, please contact the attorneys at Banville Law by calling (888) 997-3792.

###

Contact Banville Law:

Laurence Banville, Esq.
888-997-3792
info@banvillelaw.com
165 West End Avenue, #1H
New York, NY 10023
United States (US)

ReleaseID: 60006898

Go Top